Overview

This trial is active, not recruiting.

Condition prostate cancer
Treatment survey administration
Sponsor Abramson Cancer Center of the University of Pennsylvania
Start date January 2009
End date January 2013
Trial size 80 participants
Trial identifier NCT01018901, UPCC 23808

Summary

RATIONALE: Gathering information about survivors of prostate cancer and their partners may help doctors learn more about the goals for sexual functioning after cancer treatment. PURPOSE: This clinical trial is studying the goals of sexual functioning in prostate cancer survivors and their partners after cancer treatment.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
Arm
(Experimental)
Patients and their partners complete surveys. Sexual function of men is assessed by the International Index of Erectile Function; sexual function of women is assessed by the Female Sexual Function Index.
survey administration
Patients complete survey

Primary Outcomes

Measure
Goals of sexual functioning
time frame: 2 years

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Prostate cancer survivors who are: willing and able to provide informed consent; able to read, write, and speak English; married or are in married-like relationship; completed radiation or surgery for their prostate cancer 6 months to 5 years ago - Partners of prostate cancer survivors must be: willing and able to provide informed consent; able to read, write, and speak English Exclusion Criteria: - Prostate cancer survivors will be excluded if they have undergone androgen deprivation therapy within the past 6 months and if their partners refuse to participate

Additional Information

Official title Goals for Sexual Functioning of Prostate Cancer Survivors and Their Partners Following Cancer Treatment
Principal investigator James Coyne, PhD
Description Detailed DescriptionOBJECTIVES: I. To collect data on the goals of sexual functioning among prostate cancer survivors and their partners following cancer treatment in order to identify specific components of interventions for future grant submissions on the psychosexual needs of prostate cancer survivors. OUTLINE: Patients and their partners complete surveys. Sexual function of men is assessed by the International Index of Erectile Function; sexual function of women is assessed by the Female Sexual Function Index.
Trial information was received from ClinicalTrials.gov and was last updated in January 2016.
Information provided to ClinicalTrials.gov by Abramson Cancer Center of the University of Pennsylvania.